Skip to main content
Equibles

Invesco Ltd.

Position in AKBA — Akebia Therapeutics, Inc.

CIK 914208 Atlanta, GA
Back to AKBA Full portfolio

Position in AKBA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$792,216
-$208,776 QoQ
Shares Held
694,928
-3.5% QoQ
Ownership
0.251%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 170 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0% Shared 99% None 1%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $1,945,758,306 across 45 Drug Manufacturers - Specialty & Generic names. AKBA ranks #31 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 5,523,018 $396,884,069
2 VTRS
Viatris Inc
 20,771,275 $329,847,840
3 UTHR
UNITED THERAPEUTICS Corp
 473,109 $256,344,645
4 NBIX
Neurocrine Biosciences Inc
 1,077,317 $181,571,000
5 ELAN
Elanco Animal Health Inc
 5,306,326 $130,588,679
6 TEVA
Teva Pharmaceutical Industries Ltd
 3,430,011 $116,208,767
7 INDV
Indivior Pharmaceuticals, Inc.
 1,842,983 $75,617,590
8 COLL
Collegium Pharmaceutical, Inc
 1,882,499 $68,146,461

All Filings in AKBA

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $792,216 694,928
2026-03-31 $1,000,992 720,139
2025-12-31 $1,077,394 669,190
2025-09-30 $6,554,064 2,400,757
2025-06-30 $1,391,243 382,210
2025-03-31 $500,356 260,603
2024-12-31 $229,226 120,646
2024-09-30 $158,101 119,774
2024-06-30 $132,381 129,786
2024-03-31 $47,278 25,835
2023-12-31 $36,172 29,171
2023-09-30 $27,152 23,818
2023-06-30 $29,272 31,992
2022-12-31 $141,657 245,507
2022-09-30 $79,165 250,524
2022-06-30 $93,386 264,550
2022-03-31 $201,009 279,958
2021-12-31 $430,221 190,364
2021-09-30 $582,868 202,385
2021-06-30 $709,570 187,222
2021-03-31 $545,360 161,111
2020-12-31 $83,151 29,697
2020-09-30 $1,521,927 606,346
2020-06-30 $14,835,334 1,092,440
2020-03-31 $8,605,240 1,135,256